返回 Agenda
S23 : New Normal for Patients: Future Changes Brought by the Revision of the Pharmaceutical and Medical Device Act
Session Chair(s)
Kiyohito Kuno, PhD
Executive Director, Regulatory Affairs
MSD K.K., Japan
Speaker(s)
Daisuke Sato, MSc
Ministry of Health, Labour and Welfare (MHLW), Japan
Section Chief, Pharmaceutical Evaluation Division,
Takayuki Imaeda, MPharm, MS
Pfizer R&D Japan, Japan
Head of Regulatory Sciences
Yoshiyuki Majima, PhD
Pancreatic Cancer Action Network Japan, Japan
President